Last updated on April 2019

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids


Brief description of study

The primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Detailed Study Description

The study is a prospective, randomized, parallel group, double-blind, placebo-controlled phase 3 study investigating the efficacy and safety of OBE2109 alone and in combination with add-back therapy for the treatment of uterine fibroids.

Subjects will be randomized to one of 5 treatment groups in a 1:1:1:1:1 ratio.

Clinical Study Identifier: NCT03070899

Find a site near you

Start Over

Site reference ID 154

Huntington Park, CA United States
3.23miles
  Connect »

Site reference ID 185

Los Angeles, CA United States
3.23miles
  Connect »

Site reference ID 184

Cerritos, CA United States
9.29miles
  Connect »